Proxy Votes Now

Home › Activist investors › Radoff

Radoff

Campaign activist. Positions and campaigns from Radoff’s SEC filings. Updated November 20, 2026.

6current positions
2new or changed in 90 days
0active campaigns
9campaigns on record

Offer to acquire

Seer, Inc.

Offer to acquire Radoff’s latest 13D states an offer to acquire the company. It is shown as a bid, not as an activist campaign.

“Item 4 is hereby amended to add the following: On April 13, 2026, the Reporting Persons submitted a non-binding proposal to acquire 100% of the equity of the Issuer at a purchase price of $2.25 per Share in cash, representing a 33% premium to the Issuer's most recent closing price, plus a contingent value right representing the right for stockholders to receive 80% of the net proceeds received from any license, sale…” 13D, Apr 13, 2026

Active campaigns

No active campaign by this definition (see How to read this).

Current positions (6)

CompanyStakeSourceFirst disclosedLast changeSince previous filingFlagsStated intent
Harte Hanks Inc 5.7%423,447 shares Schedule 13D/A, filed Aug 24, 2026 Dec 6, 2024 Increased Aug 24, 2026 ▲ 0.10 pts Increased Seeks changes or engagement
Barnwell Industries Inc 11.4%1,680,271 shares Schedule 13D/A, filed Apr 14, 2026 Dec 2, 2025 Increased Mar 31, 2026 ▼ 1.40 pts — Seeks changes or engagement
Gse Systems Inc 7.2%250,000 shares Schedule 13D, filed Oct 11, 2024 Oct 11, 2024 — — — Seeks changes or engagement
Newpark Resources Inc — Schedule 13D/A, filed Oct 4, 2023stake not read from this filing’s format: see the filing Jul 25, 2023 — — — Standard Item 4 language
Lifevantage Corp — Schedule 13D/A, filed Jul 31, 2024stake not read from this filing’s format: see the filing Aug 11, 2023 — — — Seeks changes or engagement
Emcore Corp — Schedule 13D/A, filed Mar 8, 2024stake not read from this filing’s format: see the filing Aug 24, 2023 — — — Seeks changes or engagement

Stake: the latest 13D’s percent of the class (the largest single reporting person’s, as filed), or for a 13F the reported shares as a percent of the company’s shares outstanding on the date shown. Since previous filing: the change in percentage points against the investor’s previous 13D on the company, or its previous 13F.

Stated intent (13D Item 4)

Item 4 of a Schedule 13D (“Purpose of Transaction”) is where the investor states its plans. The label is a plain reading of that text; the excerpt is quoted from the filing.

Harte Hanks Inc · Seeks changes or engagement

“Item 4 is hereby amended to add the following: On August 14, 2026, the Issuer, Star Equity Holdings, Inc., a Delaware corporation ("Star"), and Merger Sub - R, Inc., a Delaware corporation and a wholly owned subsidiary of Star ("Merger Sub"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), pursuant to which, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will”

Item 4 in the Schedule 13D/A filed Aug 24, 2026.

Summary of the filing Radoff, a director of Harte Hanks, signed a Support Agreement to vote his shares in favor of the Issuer's merger with Star Equity Holdings, under which shareholders may elect cash of $5.00 per share or Star preferred stock.

Quoted from the filing (item 4): “cash in an amount equal to $5.00 per share (the "Cash Consideration")” Aug 24, 2026

Barnwell Industries Inc · Seeks changes or engagement

“Mr. Radoff has recommended that Joshua Schecter serve as a director to the Board, and it is expected that Mr. Schecter will join the Board following the Closing. The Purchase Agreement provides that the Issuer will register the resale of the Shares and the Warrant Shares acquired in connection with the Offering. The Issuer is required to prepare and file a registration statement with the Securities and Exchange Commission…”

Item 4 in the Schedule 13D/A filed Apr 14, 2026; this amendment did not restate Item 4, so the text is from the filing of Dec 2, 2025.

Gse Systems Inc · Seeks changes or engagement

“The Reporting Persons purchased the shares on the Reporting Persons’ belief that the Issuer’s proposed take-private merger with affiliates of Pelican Energy Partners Base Zero LP (the “Pelican Merger”) significantly undervalues the Issuer and that the consummation of the Pelican Merger at the current price is not in the best interests of the Issuer or its stockholders. The belated disclosure with incomplete projections…”

Item 4 in the Schedule 13D filed Oct 11, 2024.

Lifevantage Corp · Seeks changes or engagement

“On February 14, 2024 (the “Effective Date”), the Reporting Persons and Sudbury (collectively, the “Stockholder Parties”) entered into a Cooperation Agreement (the “Cooperation Agreement”) with the Issuer pursuant to which, among other things, the Issuer immediately (i) increased the size of its board of directors (the “Board”) by one (1) seat, to a total of eight (8) directors, and (ii) appointed Dayton Judd to the Board, with a term…”

Item 4 in the Schedule 13D/A filed Jul 31, 2024; this amendment did not restate Item 4, so the text is from the filing of Feb 15, 2024.

Emcore Corp · Seeks changes or engagement

“hereby amended to add the following: On January 10, 2024, Bradley L. Radoff and the Radoff Foundation (together, the “Radoff Parties”) entered into a Cooperation Agreement (the “Cooperation Agreement”) with the Issuer, pursuant to which the Issuer agreed, among other things, to immediately (i) accept the resignation of Chairman Stephen L. Domenik as a member of the Issuer’s board of directors (the “Board”), (ii) increase the size of the Board by”

Item 4 in the Schedule 13D/A filed Mar 8, 2024; this amendment did not restate Item 4, so the text is from the filing of Jan 11, 2024.

Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.

Past campaigns (9)
CompanyOutcome or last statusDateFirst filingHighest stageFilingsMeeting / votes
Genesco IncBoard seats Stake reported below 5% Aug 3, 2026 Apr 15, 2026 Proxy contest filed latest (13) —
Seer, Inc.Board seatsCEO or management change Bidder: offer to acquire Apr 13, 2026 Feb 20, 2026 Proxy contest filed latest (40) —
Rocky Mountain Chocolate Factory, Inc.Board seats Stake reported below 5% Sep 17, 2025 Jul 1, 2022 Proxy contest filed latest (17) —
Enzo Biochem IncBoard seats Stake reported below 5% Aug 22, 2025 Oct 19, 2021 Proxy contest filed (preliminary proxy) latest (4) —
Tetra Technologies Inc Shareholder meeting held after the soliciting material Jun 12, 2025 Mar 24, 2025 Soliciting material filed latest (3) —
Atea Pharmaceuticals, Inc.Board seats Settled (agreement with the company) Apr 17, 2025 Mar 4, 2025 Nominations made latest (8) —
Alto Ingredients, Inc. Settled (agreement with the company) Mar 18, 2025 Feb 24, 2025 — latest (4) —
Lifevantage CorpBoard seats Settled (agreement with the company) Feb 15, 2024 Aug 11, 2023 Proxy contest filed latest (14) how managers voted
Emcore CorpBoard seats Settled (agreement with the company) Jan 11, 2024 Aug 24, 2023 Nominations made latest (4) —
Past positions (8)
CompanyLast stakeSourceOutcomeDate
INVE Technologies, Inc. 4.9% Schedule 13D/A, filed Nov 5, 2026 Reported below 5% in a 13D/A Nov 5, 2026
Genesco Inc 4.8% Schedule 13D/A, filed Aug 3, 2026 Reported below 5% in a 13D/A Aug 3, 2026
Seer, Inc. 4.6% Schedule 13D/A, filed Apr 13, 2026 Reported below 5% in a 13D/A Apr 13, 2026
Rocky Mountain Chocolate Factory, Inc. 4.6% Schedule 13D/A, filed Sep 17, 2025 Reported below 5% in a 13D/A Sep 17, 2025
Enzo Biochem Inc 0.0% Schedule 13D/A, filed Aug 22, 2025 Exited Aug 22, 2025
Presidio Property Trust, Inc. 0.3% Schedule 13D/A, filed May 21, 2025 Reported below 5% in a 13D/A May 21, 2025
Atea Pharmaceuticals, Inc. 4.0% Schedule 13D/A, filed Apr 17, 2025 Reported below 5% in a 13D/A Apr 17, 2025
Alto Ingredients, Inc. 4.7% Schedule 13D/A, filed Mar 18, 2025 Reported below 5% in a 13D/A Mar 18, 2025

How large managers voted in Radoff’s proxy contests (meetings since July 2023)

Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.

Contested director elections at which Radoff had nominees on the ballot, from the managers’ N-PX vote reports and the company’s Form 8-K (Item 5.07) results. A manager “backed” a side when most of its funds’ votes on that side’s nominees were FOR; with a universal proxy card a fund can vote for nominees of both sides, so the counts are shown too.

Top 15 managers across 1 contest

ManagerBacked the activistLifevantage Corp
2023
Vanguard0 of 1 (0%) Company
Fidelity0 of 1 (0%) Company
EA Series Trust1 of 1 (100%) Activist
BlackRock0 of 1 (0%) Company
Charles Schwab0 of 1 (0%) Company
Equitable0 of 1 (0%) Company
Allianz0 of 1 (0%) Split
American Century0 of 1 (0%) Split
BRIDGEWAY FUNDS INC0 of 1 (0%) Split
Dimensional0 of 1 (0%) Split
Jackson National0 of 1 (0%) Split
Lincoln Financial0 of 1 (0%) Split
RBC FUNDS TRUST0 of 1 (0%) Split
T. Rowe Price0 of 1 (0%) Split
Victory Capital0 of 1 (0%) Split

— = no N-PX votes on the contested director elections found for that manager.

Lifevantage Corp · meeting Nov 6, 2023 · 0 of 1 of the activist’s nominees elected

Result: Form 8-K, Item 5.07. Activist’s nominees: Mr. Bradley L. Radoff (not elected (8-k tally)). Company’s nominees: Mr. Michael A. Beindorff (elected (8-k tally)); Ms. Erin Brockovich (elected (8-k tally)); Mr. Steven R. Fife (elected (8-k tally)); Mr. Raymond B. Greer (elected (8-k tally)); Ms. Cynthia Latham (elected (8-k tally)); Mr. Darwin K. Lewis (elected (8-k tally)); Mr. Garry Mauro (elected (8-k tally)); Mr. Dayton Judd (not elected (8-k tally)); Mr. Michael Lohner (not elected (8-k tally)).

ManagerStanceFOR the activist’s nomineesAvg. shares FOR each activist nomineeFOR the company’s nominees
Vanguard Backed the company's nominees 0 of 3 fund votes 0 21 of 21 fund votes
Fidelity Backed the company's nominees 0 of 4 fund votes 0 28 of 28 fund votes
EA Series Trust Backed the activist's nominees 1 of 1 fund votes 61,188 0 of 0 fund votes
BlackRock Backed the company's nominees 0 of 1 fund votes 0 7 of 7 fund votes
Charles Schwab Backed the company's nominees 0 of 1 fund votes 0 6 of 7 fund votes
Equitable Backed the company's nominees 0 of 1 fund votes 0 7 of 7 fund votes
Allianz Split 0 of 1 fund votes 0 0 of 0 fund votes
American Century Split 0 of 1 fund votes 0 0 of 0 fund votes
BRIDGEWAY FUNDS INC Split 0 of 2 fund votes 0 0 of 0 fund votes
Dimensional Split 0 of 15 fund votes 0 0 of 0 fund votes
Jackson National Split 0 of 1 fund votes 0 0 of 0 fund votes
Lincoln Financial Split 0 of 1 fund votes 0 0 of 0 fund votes
RBC FUNDS TRUST Split 0 of 1 fund votes 0 0 of 0 fund votes
T. Rowe Price Split 0 of 1 fund votes 0 0 of 0 fund votes
Victory Capital Split 0 of 1 fund votes 0 0 of 0 fund votes

Source: N-PX reports filed by 15 managers for the meeting of Nov 6, 2023; a nominee’s side is read from how most filers labelled the ballot item (two or more filers, 70% agreeing).

Track record

How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.

4Settlement
1Withdrawn
3Stake reported below 5%
1No outcome in the filings read
Outcome of each campaign (9)
CompanyOutcomeDetailDateFirst filing
Genesco Inc Withdrawn filing Jun 10, 2026 Apr 15, 2026
Seer, Inc. Stake reported below 5% filing Apr 13, 2026 Feb 20, 2026
Rocky Mountain Chocolate Factory, Inc. Stake reported below 5% filing Sep 17, 2025 Jul 1, 2022
Enzo Biochem Inc Stake reported below 5% filing Aug 22, 2025 Oct 19, 2021
Tetra Technologies Inc No outcome in the filings read — Jun 12, 2025 Mar 24, 2025
Atea Pharmaceuticals, Inc. Settlement agreement with the company Apr 17, 2025 Mar 4, 2025
Alto Ingredients, Inc. Settlement agreement with the company Mar 18, 2025 Feb 24, 2025
Lifevantage Corp Settlement agreement with the company Feb 15, 2024 Aug 11, 2023
Emcore Corp Settlement agreement with the company Jan 11, 2024 Aug 24, 2023

Share price after the first 13D

The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 2 of 14 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).

CompanyFirst 13DTo latest closeSPY same dates6 months after12 months after
Seer, Inc. SEER Feb 20, 2026 -27.3%Feb 20, 2026 – Nov 18, 2026 +5.9% +2.5%SPY +11.1% not yet / no price
Barnwell Industries Inc BRN Dec 2, 2025 -26.3%Dec 2, 2025 – Nov 18, 2026 +7.1% -3.5%SPY +10.7% not yet / no price

Prices: daily closes (Nasdaq), as stored by the site.

Settlement terms

Terms of the cooperation agreements, read by rules from the company’s Form 8-K (or the investor’s 13D where it describes the agreement). Each term is quoted from the filing; terms a rule did not find are not listed, so a missing term is not evidence that the agreement lacks it.

Atea Pharmaceuticals, Inc. · Apr 17, 2025 · Directors named
Emcore Corp · Jan 11, 2024 · Standstill

Other disclosed holders around the same time

Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Radoff’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.

Genesco Inc · Radoff first disclosed Apr 15, 2026 · 2 other filings
HolderFormDateStake
Pzena Investment Management LLC Schedule 13G Jan 30, 2026 11.5%
Fund 1 Investments, LLC Schedule 13G May 15, 2026 3.9%
Barnwell Industries Inc · Radoff first disclosed Dec 2, 2025 · 2 other filings
HolderFormDateStake
Barnwell Industries, Inc. Employees' Pension Plan Trust Schedule 13D Jul 3, 2025 5.2%
JCP Investment Schedule 13D Apr 17, 2026 5.1%
Enzo Biochem Inc · Radoff first disclosed Jun 25, 2025 · 2 other filings
HolderFormDateStake
Harbert Discovery Schedule 13D Jun 25, 2025 9.9%
Battery Ventures XIV, L.P. Schedule 13D Jun 30, 2025 21.8%
Tetra Technologies Inc · Radoff first disclosed Mar 24, 2025 · 1 other filing
HolderFormDateStake
Pictet Asset Management SA Schedule 13D Apr 15, 2025 5.3%
Atea Pharmaceuticals, Inc. · Radoff first disclosed Mar 4, 2025 · 5 other filings
HolderFormDateStake
BML Investment Partners, L.P. Schedule 13D Dec 16, 2024 8.5%
EcoR1 Capital, LLC Schedule 13G Feb 14, 2025 4.0%
BlackRock, Inc. Schedule 13G Apr 23, 2025 7.1%
Jean-Pierre Sommadossi Schedule 13G May 14, 2025 10.1%
FMR LLC Schedule 13G Aug 6, 2025 6.7%
Alto Ingredients, Inc. · Radoff first disclosed Feb 24, 2025 · 1 other filing
HolderFormDateStake
DOMO Capital Management, LLC Schedule 13G Jan 7, 2025 7.1%
Harte Hanks Inc · Radoff first disclosed Dec 6, 2024 · 1 other filing
HolderFormDateStake
Gary S. Rosenbach Schedule 13D May 30, 2025 28.8%
Gse Systems Inc · Radoff first disclosed Oct 11, 2024 · 1 other filing
HolderFormDateStake
Loudermilk Kyle Justin Schedule 13D May 6, 2024 5.7%
Rocky Mountain Chocolate Factory, Inc. · Radoff first disclosed Aug 4, 2023 · 1 other filing
HolderFormDateStake
Global Value Investment Corp. Schedule 13D Jul 21, 2023 21.1%

How to read this

Flags (last 90 days)
New first disclosed in the last 90 days. Increased / Decreased shares up or down in a 13D/A or 13F filed in that time. Below 5% a 13D/A reported less than 5%, the reporting threshold. Exited a 13D/A reported no shares, or the investor’s 13F no longer lists a company it listed before.
Active campaign
A contested meeting at which the investor is soliciting proxies is still to be held; or in the last 12 months it filed a proxy-contest document (PREC14A, DEFC14A or DFAN14A soliciting material), stated in a 13D that it nominated directors, filed a letter or presentation to the board or shareholders, or stated public demands in a 13D — and no settlement, withdrawal, contested vote or 13D below 5% is dated on or after the latest such filing. Status is the furthest step since then: Public demands in a 13D < Public letter or soliciting material < Nominations made < Proxy contest filed.
Sources and limits
SEC EDGAR only. 13D data covers filings since June 2023; 13F reports are quarterly and filed up to 45 days after the quarter, and do not show swaps, most options or non-US holdings. Settlements are cooperation agreements disclosed in the company’s 8-K or stated in the investor’s 13D; board seats are read from the 8-K. Text marked Summary of the filing is checked against the filing, whose words are quoted beside it. Nothing on this page predicts what the investor will do.